Nanobubble Ozone Stored in Hyaluronic Acid Decorated Liposomes: Antibacterial, Anti-SARS-CoV-2 Effect and Biocompatibility Tests

References

• Ratz-lyko A, Arct J, Pytkowska K. Moisturizing and anti-inflammatory properties of cosmetic formulations containing Centella Asiatica extract. Indian J Pharm Sci. 2016;78(1):27. doi:10.4103/0250-474X.180247
   PubMed Web of Science ®Google Scholar
• M. Nabil Mawsouf, M.M. El-Sawalhi,G. Martínez-Sánchez, H.A. Darwish,A.A. Shaheen, L. Re. Effect of ozone therapy on redox status in experimentally induced arthritis. Int J Ozone Ther. 2010;9(1):7–13.
   Google Scholar
• Bocci V. OZONE a New Medical Drug. Softcover reprint of hardcover. 1st ed. Springer; 2010.
   Google Scholar
• Seyman D, Ozen NS, Inan D, Ongut G, Ogunc D. Pseudomonas aeruginosa septic arthritis of knee after intra-articular ozone injection. New Microbiol. 2012;35(3):345–348.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Dong M, Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID‐19. J Med Virol. 2020;92(11):2348–2350. doi:10.1002/jmv.26040
   PubMed Web of Science ®Google Scholar
• Rowen RJ, Robins H. Ozone therapy for complex regional pain syndrome: review and case report. Curr Pain Headache Rep. 2019;23(6):41. doi:10.1007/s11916-019-0776-y
   PubMed Web of Science ®Google Scholar
• Seydanur Dengizek E, Serkan D, Abubekir E, Aysun Bay K, Onder O, Arife C. Evaluating clinical and laboratory effects of ozone in non-surgical periodontal treatment: a randomized controlled trial. J Appl Oral Sci. 2019;27:1–8. doi:10.1590/1678-7757-2018-0108
   Web of Science ®Google Scholar
• Sconza C, Respizzi S, Virelli L, et al. Oxygen–ozone therapy for the treatment of knee osteoarthritis: a systematic review of randomized controlled trials. Arthroscopy. 2020;36(1):277–286. doi:10.1016/j.arthro.2019.05.043
   PubMed Web of Science ®Google Scholar
• Fernández-Cuadros ME. Ozone Fundamentals and Effectiveness on Knee Pain: Chondromalacia and Knee Osteoarthritis. LAP LAMBERT Academic Publishing; 2016.
   Google Scholar
• Fernández-Cuadros ME, Pérez-Moro OS, Albaladejo-Florin MJ, Alava-Rabasa S. El ozono intraarticular modula la inflamación, mejora el dolor, la rigidez, la función y tiene un efecto anabólico sobre la artrosis de rodilla: estudio cuasi-experimental prospectivo tipo antes-después, 115 pacientes. Revista de La Sociedad Española Del Dolor. 2020;27:78–86. doi:10.20986/resed.2020.3775/2019
   Google Scholar
• Alkan PE, Güneş M, Özakin C, Sabanci A. New antibacterial agent: nanobubble ozone stored in liposomes: the antibacterial activity of nanobubble ozone in liposomes and their thymol solutions. Ozone Sci Eng. 2021;1–5. doi:10.1080/01919512.2021.1904205
   Web of Science ®Google Scholar
• Monzillo V, Lallitto F, Russo A, et al. Ozonized gel against four candida species: a pilot study and clinical perspectives. Materials. 2020;13(7):1731. doi:10.3390/ma13071731
   PubMed Web of Science ®Google Scholar
• Jakab GJ, Hmieleski RR. Reduction of influenza virus pathogenesis by exposure to 0.5 ppm ozone. J Toxicol Environ Health. 1988;23(4):455–472. doi:10.1080/15287398809531128
   PubMed Web of Science ®Google Scholar
• Finch GR, Black EK, Labatiuk CW, Gyürék L, Belosevic M. Comparison of Giardia lamblia and Giardia muris cyst inactivation by ozone. Appl Environ Microbiol. 1993;59(11):3674–3680. doi:10.1128/aem.59.11.3674-3680.1993
   PubMed Web of Science ®Google Scholar
• Criegee R. Mechanism of Ozonolysis. Angew Chem Int Ed Engl. 1975;14(11):745–752. doi:10.1002/anie.197507451
   Web of Science ®Google Scholar
• Song M, Zeng Q, Xiang Y, et al. The antibacterial effect of topical ozone on the treatment of MRSA skin infection. Mol Med Rep. 2017;17:2449–2455. doi:10.3892/mmr.2017.8148
   PubMed Web of Science ®Google Scholar
• Russo T, Currò M, Ferlazzo N, et al. Stable ozonides with vitamin E acetate versus corticosteroid in the treatment of lichen sclerosus in foreskin: evaluation of effects on inflammation. Urol Int. 2019;103(4):459–465. doi:10.1159/000499846
   PubMed Web of Science ®Google Scholar
• Xiao W, Tang H, Wu M, et al. Ozone oil promotes wound healing by increasing the migration of fibroblasts via PI3K/Akt/mTOR signaling pathway. Biosci Rep. 2017;37(6):1–9. doi:10.1042/BSR20170658
   Web of Science ®Google Scholar
• Murata T, Komoto S, Iwahori S, et al. Reduction of severe acute respiratory syndrome coronavirus‐2 infectivity by admissible concentration of ozone gas and water. Microbiol Immunol. 2020;65(1):10–16. doi:10.1111/1348-0421.12861
   PubMed Web of Science ®Google Scholar
• Franzini M, Valdenassi L, Ricevuti G, et al. Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int Immunopharmacol. 2020;88:106879. doi:10.1016/j.intimp.2020.106879
   PubMed Web of Science ®Google Scholar
• Hernández A, Viñals M, Pablos A, et al. Ozone therapy for patients with COVID-19 pneumonia: preliminary report of a prospective case-control study. Int Immunopharmacol. 2021;90:107261. doi:10.1016/j.intimp.2020.107261
   PubMed Web of Science ®Google Scholar
• Tascini C, Sermann G, Pagotto A, et al. Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience. Intern Emerg Med. 2020;16(3):669–675. doi:10.1007/s11739-020-02542-6
   PubMed Web of Science ®Google Scholar
• Fernández-Cuadros ME, Albaladejo-Florín MJ, Álava-rabasa S, et al. Effect of rectal ozone (O3) in severe COVID-19 pneumonia: preliminary results. SN Compr Clin Med. 2020;2(9):1328–1336. doi:10.1007/s42399-020-00374-1
   PubMedGoogle Scholar
• Bateman RM, Sharpe MD, Ellis CG. Bench-to-bedside review: microvascular dysfunction in sepsis – hemodynamics, oxygen transport, and nitric oxide. Crit Care. 2003;7(5):359–373. doi:10.1186/cc2353
   PubMed Web of Science ®Google Scholar
• Giunta R, Coppola A, Luongo C, et al. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann Hematol. 2001;80:745–748. doi:10.1007/s002770100377
   PubMed Web of Science ®Google Scholar
• Wu XN, Zhang T, Wang J, et al. Magnetic resonance diffusion tensor imaging following major ozonated autohemotherapy for treatment of acute cerebral infarction. Neural Regen Res. 2016;11(7):1115–1121. doi:10.4103/1673-5374.187046
   PubMed Web of Science ®Google Scholar
• Borroto RV, Lima HLB, Lima GS, et al. Prevention of the stroke with the application of ozone therapy. Rev Cub Med Fis Rehab. 2013;5(1):3–16.
   Google Scholar
• Pandolfi S, Zammitti A, Franzini M, et al. Effects of oxygen ozone therapy on cardiac function in a patient with a prior myocardial infarction. Ozone Ther. 2017;2(1). doi:10.4081/ozone.2017.6745
   Google Scholar
• Clavo B, Suarez G, Aguilar Y, et al. Brain ischemia and hypometabolism treated by ozone therapy. Forsch Komplementmed. 2011;18(5):283–287. doi:10.1159/000333795
   PubMedGoogle Scholar
• Kekez MM, Sattar SA. A new ozone-based method for virus inactivation: preliminary study. Phys Med Biol. 1997;42:2027–2039. doi:10.1088/0031-9155/42/11/002
   PubMed Web of Science ®Google Scholar
• Shin GA, Sobsey MD. Reduction of Norwalk virus, poliovirus 1, and bacteriophage MS2 by ozone disinfection of water. Appl Environ Microbiol. 2003;69:3975–3978. doi:10.1128/AEM.69.7.3975-3978.2003
   PubMed Web of Science ®Google Scholar
• Herbold K, Flehmig B, Botzenhart K. Comparison of ozone inactivation, in flowing water, of hepatitis A virus, poliovirus 1, and indicator organisms. Appl Environ Microbiol. 1989;55:2949–2953. doi:10.1128/aem.55.11.2949-2953.1989
   PubMed Web of Science ®Google Scholar
• Katzenelson E, Koerner G, Biedermann N, Peleg M, Shuval HI. Measurement of the inactivation kinetics of polio virus by ozone in a fast-flow mixer. Appl Environ Microbiol. 1979;37:715–718. doi:10.1128/aem.37.4.715-718.1979
   PubMed Web of Science ®Google Scholar
• Roy D, Wong PK, Engelbrecht RS, Chian ES. Mechanism of enteroviral inactivation by ozone. Appl Environ Microbiol. 1981;41:718–723. doi:10.1128/aem.41.3.718-723.1981
   PubMed Web of Science ®Google Scholar
• Rowen RJ, Robins H. A plausible “Penny” costing effective treatment for corona virus - ozone therapy. J Infect Dis Epidemiol. 2020;6(2):1–5.
   Google Scholar
• Mirazimi A, Mousavi-Jazi M, Sundqvist VA, Svensson L. Free thiol groups are essential for infectivity of human cytomegalovirus. J Gen Virol. 1999;80:2861–2865. doi:10.1099/0022-1317-80-11-2861
   PubMed Web of Science ®Google Scholar
• Markovic I, Stantchev TS, Fields KH, et al. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. Blood. 2004;103:1586–1594. doi:10.1182/blood-2003-05-1390
   PubMed Web of Science ®Google Scholar
• Lee JE, Saphire EO. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol. 2009;4:621–635. doi:10.2217/fvl.09.56
   PubMed Web of Science ®Google Scholar
• Madu IG, Belouzard S, Whittaker GR. SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Virology. 2009;393(2):265–271. doi:10.1016/j.virol.2009.07.038
   PubMed Web of Science ®Google Scholar
• Pandey A, Nikam AN, Mutalik SP, et al. Architectured therapeutic and diagnostic nanoplatforms for combating SARS-CoV-2: role of inorganic, organic, and radioactive materials. ACS Biomater Sci Eng. 2020;7(1):31–54. doi:10.1021/acsbiomaterials.0c01243
   PubMed Web of Science ®Google Scholar
• Koo H, Huh MS, Sun IC, et al. In vivo targeted delivery of nanoparticles for theranosis. Acc Chem Res. 2011;44(10):1018–1028. doi:10.1021/ar2000138
   PubMed Web of Science ®Google Scholar
• Abo-zeid Y, Urbanowicz RA, Thomson BJ, Irving WL, Tarr AW, Garnett MC. Enhanced nanoparticle uptake into virus infected cells: could nanoparticles be useful in antiviral therapy? Int J Pharm. 2018;547(1–2):572–581. doi:10.1016/j.ijpharm.2018.06.027
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. CLSI standart M07. 11th ed. Wayne,PA: Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Xie X, Muruato A, Lokugamage KG, et al. An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe. 2020;27(5):841–848.e3. doi:10.1016/j.chom.2020.04.004
   PubMed Web of Science ®Google Scholar
• Alkan PE, Güneş ME, Özakin C, Sabanci AÜ. New antibacterial agent: nanobubble ozone stored in liposomes: the antibacterial activity of nanobubble ozone in liposomes and their thymol solutions. Ozone Sci Eng. 2021;43(6):637–641. doi:10.1080/01919512.2021.1904205
   Web of Science ®Google Scholar
• Erkan-Alkan P, Güneş ME, Özakın C, Sabancı AÜ. [Nanoparticle liposomes: a new strategy in bacterial infections]. Klimik Derg. 2021;34(2):99–102. Turkish. doi:10.36519/kd.2021.3633
   Web of Science ®Google Scholar
• Borges GÁ, Elias ST, da Silva SM, et al. In vitro evaluation of wound healing and antimicrobial potential of ozone therapy. Journal of Cranio-Maxillofacial Surgery. 2017;45(3):364–370. doi:10.1016/j.jcms.2017.01.005
   PubMed Web of Science ®Google Scholar
• Clavo B, Córdoba-Lanús E, Rodríguez-Esparragón F, et al. Effects of ozone treatment on personal protective equipment contaminated with SARS-CoV-2. Antioxidants. 2020;9:1222. doi:10.3390/antiox9121222
   Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Mao P, Wu S, Li J, et al. Human alveolar epithelial type II cells in primary culture. Physiol Rep. 2015;3(2):e12288. doi:10.14814/phy2.12288
   PubMedGoogle Scholar
• Fulcher ML, Randell SH. Human nasal and tracheo-bronchial respiratory epithelial cell culture. Methods Mol Biol. 2013;945:109–121.
   PubMedGoogle Scholar
• Stevens A, Wilson I. The haematoxylins and eosin. In: Bancroft JD, Stevens A, editors. Theory and Practice of Histological Techniques. 4th ed. Hong Kong: Churchill Livingstone; 1999:99–112.
   Google Scholar
• Yoon JG, Yoon J, Song JY, et al. Clinical significance of a high SARS-CoV-2 viral load in the saliva. J Korean Med Sci. 2020;35(20):1–5. doi:10.3346/jkms.2020.35.e195
   Web of Science ®Google Scholar
• Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177–1179. doi:10.1056/NEJMc2001737
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi:10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454. doi:10.1038/nature02145
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280.e8. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Matsuyama S, et al. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol. 2010;84:12658–12664. doi:10.1128/JVI.01542-10
   PubMed Web of Science ®Google Scholar
• Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N. TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J Virol. 2019;93. doi:10.1128/JVI.01815-18
   Web of Science ®Google Scholar
• Sungnak W, Huang N, Bécavin C, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681–687. doi:10.1038/s41591-020-0868-6
   PubMed Web of Science ®Google Scholar
• Zhong M, Lin B, Pathak JL, et al. ACE2 and furin expressions in oral epithelial cells possibly facilitate COVID-19 infection via respiratory and fecal-oral routes. Front Med. 2020;7:580796. doi:10.3389/fmed.2020.580796
   Web of Science ®Google Scholar
• Singapore Standards Council. Standard Guide for Accelerated Aging of Sterile Barrier Systems for Medical Devices. Enterprise Singapore; 2020.
   Google Scholar
• He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672–675. doi:10.1038/s41591-020-0869-5
   PubMed Web of Science ®Google Scholar
• Ramalingam S, Graham C, Dove J, Morrice L, Sheikh A. A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold. Sci Rep. 2019;9(1):1–9. doi:10.1038/s41598-018-37703-3
   PubMed Web of Science ®Google Scholar
• Rabago D, Zgierska A. Saline nasal irrigation for upper respiratory conditions. Am Fam Phys. 2009;80(10):1117–1119.
   PubMed Web of Science ®Google Scholar
• Chatterjee U, Chakraborty A, Naskar S, Saha B, Bandyapadhyay B, Shee S. Efficacy of normal saline nasal spray and gargle on SARS-CoV-2 for prevention of COVID-19 pneumonia. Res Sq. 2021;1–7. doi:10.21203/rs.3.rs-153598/v2
   Google Scholar
• Ludwig M, Enzenhofer E, Schneider S, et al. Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial. Respir Res. 2013;14(1):124. doi:10.1186/1465-9921-14-124
   PubMed Web of Science ®Google Scholar
• Giarratana N, Rajan B, Kamala K, Mendenhall M, Reiner G. A sprayable acid-oxidizing solution containing hypochlorous acid (AOS2020) efficiently and safely inactivates SARS-Cov-2: a new potential solution for upper respiratory tract hygiene. Eur Arch Otorhinolaryngol. 2021:1–5. doi:10.1007/s00405-020-06112-6
   Web of Science ®Google Scholar
• Shmuel K, Dalia M, Tair L, Yaakov N. Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: an observational prospective open label user survey. Expert Rev Anti Infect Ther. 2021;19:1325–1330.
   PubMed Web of Science ®Google Scholar
• Anderson DE, Sivalingam V, Kang AEZ, et al. Povidone-iodine demonstrates rapid in vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 disease. Infect Dis Ther. 2020;9(3):669–675. doi:10.1007/s40121-020-00316-3
   PubMed Web of Science ®Google Scholar
• PVP-I nasal sprays and SARS-CoV-2 nasopharyngeal titers (for COVID-19) - full text view - ClinicalTrials.gov. Clinical Trials; 2021.
   Google Scholar
• Braga SS. Cyclodextrins: emerging medicines of the new millennium. Biomolecules. 2019;9(12):801. doi:10.3390/biom9120801
   PubMed Web of Science ®Google Scholar
• Ergoren MC, Paolacci S, Manara E, et al. A pilot study on the preventative potential of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 transmission. Acta Biomed. 2020;91(Supplement 13):e2020022. doi:10.23750/abm.v91i13-S.10817
   PubMedGoogle Scholar
• Carrouel F, Gonçalves L, Conte M, et al. Antiviral activity of reagents in mouth rinses against SARS-CoV-2. J Dent Res. 2020;100(2):124–132. doi:10.1177/0022034520967933
   PubMed Web of Science ®Google Scholar
• Altaş B, Koçak H, Sltınay S, Yücabaş K, Taşkın M, Oktay F. Is ozone (O3) treatment effective in atrophic rhinitis: experimental animal study. Otolaryngol Polska. 2018;72(5):37–44. doi:10.5604/01.3001.0012.1265
   PubMed Web of Science ®Google Scholar
• Shah M, Captain J, Vaidya V, et al. Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: a phase 1/11 randomized control trial (SEOT study). Int Immunopharmacol. 2021;91:107301. doi:10.1016/j.intimp.2020.107301
   PubMed Web of Science ®Google Scholar
• Cattel F, Giordano S, Bertiond C, et al. Ozone therapy in COVID-19: a narrative review. Virus Res. 2021;291:198207. doi:10.1016/j.virusres.2020.198207
   PubMed Web of Science ®Google Scholar
• Tizaoui C. Ozone: a potential oxidant for COVID-19 virus (SARSCoV-2). Ozone Sci Eng. 2020;42(5):378–385. doi:10.1080/01919512.2020.1795614
   Web of Science ®Google Scholar
• Casale M, Moffa A, Sabatino L, et al. Hyaluronic acid: perspectives in upper aero-digestive tract. A systematic review. PLoS One. 2015;10(6):e0130637. doi:10.1371/journal.pone.0130637
   PubMed Web of Science ®Google Scholar
• Mösges R, Baena-Cagnani CE, Passali D. Nonpharmacological treatment of rhinoconjunctivitis and rhinosinusitis. J Allergy. 2014;(2014:1–2. doi:10.1155/2014/416236
   Google Scholar
• El Kechai N, Geiger S, Fallacara A, et al. Mixtures of hyaluronic acid and liposomes for drug delivery: phase behavior, microstructure and mobility of liposomes. Int J Pharm. 2017;523(1):246–259. doi:10.1016/j.ijpharm.2017.03.029
   PubMed Web of Science ®Google Scholar
• Arpicco S, Lerda C, Dalla Pozza E, et al. Hyaluronic acid-coated liposomes for active targeting of gemcitabine. hyaluronic acid-coated liposomes for active targeting of gemcitabine. Eur J Pharm Biopharm. 2013;85:373–380. doi:10.1016/j.ejpb.2013.06.003
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:57. doi:10.3390/pharmaceutics10020057
   PubMed Web of Science ®Google Scholar
• Schreiner TB, Santamaria-Echart A, Ribeiro A, et al. Formulation and optimization of nanoemulsions using the natural surfactant saponin from quillaja bark. Molecules. 2020b;25(7):1538. doi:10.3390/molecules25071538
   PubMed Web of Science ®Google Scholar
• Creech, C. B., Walker, S. C., & Samuels, R. J. SARS-CoV-2 Vaccines. JAMA, 2021; 325(13), 1318. doi:10.1001/jama.2021.3199
   Google Scholar